{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:31:00Z","timestamp":1792549860415,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jconrel.2024.10.019","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T01:46:17Z","timestamp":1729302377000},"page":"369-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Neoantigen sequestrated autophagosomes as therapeutic cancer vaccines"],"prefix":"10.1016","volume":"376","author":[{"given":"Jinxie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuchang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunwan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.10.019_bb0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0020","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jconrel.2023.02.015","article-title":"Vaccine-like nanomedicine for cancer immunotherapy","volume":"355","author":"Yi","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jconrel.2022.10.004","article-title":"Nanomedicine for advanced cancer immunotherapy","volume":"351","author":"Diep","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-med-042617-101816","article-title":"Harnessing tumor mutations for truly individualized cancer vaccines","volume":"70","author":"Vormehr","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0065","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-18-1494","article-title":"Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers","volume":"9","author":"Parkhurst","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0080","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1038\/s41467-023-38946-z","article-title":"Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors","volume":"14","author":"Schmidt","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0090","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0095","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/s41591-019-0596-y","article-title":"Developing neoantigen-targeted T cell\u2013based treatments for solid tumors","volume":"25","author":"Yamamoto","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0100","doi-asserted-by":"crossref","first-page":"xii11","DOI":"10.1093\/annonc\/mdx681","article-title":"Preclinical and clinical development of neoantigen vaccines","volume":"28","author":"Li","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41591-020-01206-4","article-title":"Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma","volume":"27","author":"Hu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150535","article-title":"Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma","volume":"132","author":"Kristensen","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0140","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-019-13438-1","article-title":"CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities","volume":"10","author":"Ahrends","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4+ T cells in CD8+ T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0150","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-019-10594-2","article-title":"Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade","volume":"10","author":"D\u2019Alise","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s43018-022-00352-7","article-title":"Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jconrel.2023.11.057","article-title":"Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications","volume":"365","author":"Yang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0170","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jconrel.2023.11.013","article-title":"An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy","volume":"364","author":"Gong","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0175","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/15548627.2017.1378838","article-title":"Autophagy pathway: cellular and molecular mechanisms","volume":"14","author":"Yu","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2023.12.032","article-title":"Autophagy-modulating biomembrane nanostructures: a robust anticancer weapon by modulating the inner and outer cancer environment","volume":"366","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0190","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","article-title":"Autophagy in healthy aging and disease","volume":"1","author":"Aman","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0195","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/15548627.2015.1045178","article-title":"Differential use of autophagy by primary dendritic cells specialized in cross-presentation","volume":"11","author":"Mintern","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0200","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0205","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ni.1720","article-title":"Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection","volume":"10","author":"English","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0215","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1158\/1078-0432.CCR-11-0812","article-title":"Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism","volume":"17","author":"Twitty","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0220","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1158\/0008-5472.CAN-08-0161","article-title":"Efficient cross-presentation depends on autophagy in tumor cells","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0225","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","article-title":"The roles of extracellular vesicles in the immune system","volume":"23","author":"Buzas","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0240","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.febslet.2014.06.015","article-title":"Regulation of autophagy: modulation of the size and number of autophagosomes","volume":"588","author":"Jin","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0245","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41580-020-0241-0","article-title":"Mechanisms governing autophagosome biogenesis","volume":"21","author":"Nakatogawa","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0250","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/acsnano.8b07371","article-title":"Surgical tumor-derived personalized Photothermal vaccine formulation for Cancer immunotherapy","volume":"13","author":"Ye","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0255","article-title":"Recent advances in drug delivery nanocarriers incorporated in temperature-sensitive pluronic F-127\u2013a critical review","volume":"72","author":"Jaquilin","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0260","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2007.03.007","article-title":"Formulation and in vitro characterization of an in situ gelable, photo-polymerizable pluronic hydrogel suitable for injection","volume":"119","author":"Lee","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0265","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-pharmtox-010716-104936","article-title":"Autophagy: a druggable process","volume":"57","author":"Morel","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-3659(02)00271-7","article-title":"Pluronic\u00ae F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle","volume":"85","author":"Wenzel","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0280","first-page":"445","article-title":"Extended tacrolimus release via the combination of lipid-based solid dispersion and HPMC hydrogel matrix tablets","volume":"14","author":"Xu","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0285","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0290","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0295","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0300","first-page":"549","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy, protein","volume":"11","author":"Liu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.10.019_bb0305","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8+ T cell subsets in antitumor immunity","volume":"30","author":"Paul","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0315","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression\u2014implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-cancerbio-030419-033428","article-title":"Regulatory T cells in cancer","volume":"4","author":"Plitas","year":"2020","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.jconrel.2024.10.019_bb0325","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T08:35:47Z","timestamp":1733560547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924006928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S0168365924006928"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoantigen sequestrated autophagosomes as therapeutic cancer vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}